388 related articles for article (PubMed ID: 26667374)
1. Modeling neurodevelopmental cognitive deficits in tasks with cross-species translational validity.
Cope ZA; Powell SB; Young JW
Genes Brain Behav; 2016 Jan; 15(1):27-44. PubMed ID: 26667374
[TBL] [Abstract][Full Text] [Related]
2. Ultrasonic vocalizations in Shank mouse models for autism spectrum disorders: detailed spectrographic analyses and developmental profiles.
Wöhr M
Neurosci Biobehav Rev; 2014 Jun; 43():199-212. PubMed ID: 24726578
[TBL] [Abstract][Full Text] [Related]
3. The clinical-basic interface in defining pathogenesis in disorders of neurodevelopmental origin.
Thompson BL; Levitt P
Neuron; 2010 Sep; 67(5):702-12. PubMed ID: 20826303
[TBL] [Abstract][Full Text] [Related]
4. Developing predictive animal models and establishing a preclinical trials network for assessing treatment effects on cognition in schizophrenia.
Floresco SB; Geyer MA; Gold LH; Grace AA
Schizophr Bull; 2005 Oct; 31(4):888-94. PubMed ID: 16079387
[TBL] [Abstract][Full Text] [Related]
5. Developing treatments for cognitive deficits in schizophrenia: the challenge of translation.
Young JW; Geyer MA
J Psychopharmacol; 2015 Feb; 29(2):178-96. PubMed ID: 25516372
[TBL] [Abstract][Full Text] [Related]
6. Developing translational animal models for symptoms of schizophrenia or bipolar mania.
Geyer MA
Neurotox Res; 2008 Aug; 14(1):71-8. PubMed ID: 18790726
[TBL] [Abstract][Full Text] [Related]
7. Development of cross-species translational paradigms for psychiatric research in the Research Domain Criteria era.
Young JW
Neurosci Biobehav Rev; 2023 May; 148():105119. PubMed ID: 36889561
[TBL] [Abstract][Full Text] [Related]
8. Developmental trajectory of cognitive impairment in bipolar disorder: comparison with schizophrenia.
Bora E
Eur Neuropsychopharmacol; 2015 Feb; 25(2):158-68. PubMed ID: 25261263
[TBL] [Abstract][Full Text] [Related]
9. GlyT-1 Inhibition Attenuates Attentional But Not Learning or Motivational Deficits of the Sp4 Hypomorphic Mouse Model Relevant to Psychiatric Disorders.
Young JW; Kamenski ME; Higa KK; Light GA; Geyer MA; Zhou X
Neuropsychopharmacology; 2015 Nov; 40(12):2715-26. PubMed ID: 25907107
[TBL] [Abstract][Full Text] [Related]
10. Consideration of species differences in developing novel molecules as cognition enhancers.
Young JW; Jentsch JD; Bussey TJ; Wallace TL; Hutcheson DM
Neurosci Biobehav Rev; 2013 Nov; 37(9 Pt B):2181-93. PubMed ID: 23064177
[TBL] [Abstract][Full Text] [Related]
11. [Neurodevelopmental hypothesis of schizophrenia].
Thibaut F
Encephale; 2006 Oct; 32(5 Pt 4):S879-82; discussion S883. PubMed ID: 17119493
[No Abstract] [Full Text] [Related]
12. Cognitive endophenotypes, gene-environment interactions and experience-dependent plasticity in animal models of schizophrenia.
Burrows EL; Hannan AJ
Biol Psychol; 2016 Apr; 116():82-9. PubMed ID: 26687973
[TBL] [Abstract][Full Text] [Related]
13. Cognitive [Computational] Neuroscience Test Reliability and Clinical Applications for Serious Mental Illness (CNTRaCS) Consortium: Progress and Future Directions.
Barch DM; Boudewyn MA; Carter CC; Erickson M; Frank MJ; Gold JM; Luck SJ; MacDonald AW; Ragland JD; Ranganath C; Silverstein SM; Yonelinas A
Curr Top Behav Neurosci; 2023; 63():19-60. PubMed ID: 36173600
[TBL] [Abstract][Full Text] [Related]
14. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
Jabben N; Arts B; van Os J; Krabbendam L
J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
[TBL] [Abstract][Full Text] [Related]
15. Autism spectrum disorders: developmental disconnection syndromes.
Geschwind DH; Levitt P
Curr Opin Neurobiol; 2007 Feb; 17(1):103-11. PubMed ID: 17275283
[TBL] [Abstract][Full Text] [Related]
16. Harnessing cognitive neuroscience to develop new treatments for improving cognition in schizophrenia: CNTRICS selected cognitive paradigms for animal models.
Moore H; Geyer MA; Carter CS; Barch DM
Neurosci Biobehav Rev; 2013 Nov; 37(9 Pt B):2087-91. PubMed ID: 24090823
[TBL] [Abstract][Full Text] [Related]
17. Understanding zebrafish cognition.
Meshalkina DA; Kizlyk MN; Kysil EV; Collier AD; Echevarria DJ; Abreu MS; Barcellos LJG; Song C; Kalueff AV
Behav Processes; 2017 Aug; 141(Pt 2):229-241. PubMed ID: 27919782
[TBL] [Abstract][Full Text] [Related]
18. Why bother using non-human primate models of cognitive disorders in translational research?
Camus S; Ko WK; Pioli E; Bezard E
Neurobiol Learn Mem; 2015 Oct; 124():123-9. PubMed ID: 26135120
[TBL] [Abstract][Full Text] [Related]
19. Conceptual issues in neurodevelopmental disorders: lives out of synch.
Clegg J; Gillott A; Jones J
Curr Opin Psychiatry; 2013 May; 26(3):289-94. PubMed ID: 23519204
[TBL] [Abstract][Full Text] [Related]
20. Applying new approaches from cognitive neuroscience to enhance drug development for the treatment of impaired cognition in schizophrenia.
Carter CS
Schizophr Bull; 2005 Oct; 31(4):810-5. PubMed ID: 16107584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
